Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Expression of the collagen-like putative oncoprotein ofHerpesvirus saimiri in transformed T cells

  • 24 Accesses

  • 17 Citations


Herpesvirus saimiri induces acute lymphomas and leukemias in New World primates and rabbits. Previous work revealed that a highly oncogenic group C strain 484–77 encodes and expresses a bicistronic mRNA in tumor-derived T cells and the first open reading frame (orf1) is highly homologous to collagen. With the aid of an antibody against a synthetic orf1 peptide, we now report that the orf1 collagen-like protein is expressed in rabbit tumor derived cell lines and in vitro transformed human and monkey T cells. The orf1 protein is expressed in vivo, as indicated by specific antibodies detected in the serum from a tumor-bearing rabbit.

This is a preview of subscription content, log in to check access.


  1. 1.

    Roizman B. in Roizman B. (ed).The Herpesviruses, I. Plenum Publishing, New York, 1982, pp. 1–23.

  2. 2.

    Roizman B., Carmichael L.E., Deinhardt F., de-The G., Nahmias A.J., Plowright W., Rapp F., Sheldrick P., Tadahashi M., and Wold K., Intervirology10 201–217, 1981.

  3. 3.

    Melendez L., Daniel M.D., Hunt R.D., and Garcia F.G., Lab Anim Care18 374–381, 1968.

  4. 4.

    Melendez L., Hunt R.D., Daniel M.D., Garcia F., and Fraser C.E.O., Lab Anim Care19 378–386, 1969.

  5. 5.

    Daniel M.D., Melendez L.V., Hunt R.D., King N.W., Anver M., Fraser C.E.O., Barahona H.H., and Baggs R.B., J Natl Cancer Inst53 1803–1807, 1974.

  6. 6.

    Medveczky M.M., Szomolanyi E., Hesselton R., DeGrand D., Geck P., and Medveczky P.G., J Virol63 3601–3611, 1989.

  7. 7.

    Neubauer R.H., Briggs C.J., Noer K.B., and Rabin H., J Immunol130 1323–1329, 1983.

  8. 8.

    Johnson D.R. and Jondal M., Nature291 81–83, 1981.

  9. 9.

    Bornkamm G., Delius H., Fleckenstein B., Werner F.J., and Mulder C., J Virol25 154–161, 1976.

  10. 10.

    Koomey J.M., Mulder C., Burghoff R.L., Fleckenstein B., and Desrosiers R.C., J Virol50 662–665, 1984.

  11. 11.

    Schaffer P.A., Falk L.A., and Deinhardt F., J Natl Cancer Inst55 1243–1246, 1975.

  12. 12.

    Daniel M.D., Silva D., Koomey J.M., Mulder C., Fleckenstein B., Tamulevich R., King N.W., Hunt R.D., Sehgal P., and Falk L.A. in D.S. Yohn, B.A. Lapin, and J.R. Blakeslee (eds).Advances in Comparative Leukemia Research. Elsevier/North Holland, New York, 1979.

  13. 13.

    Kaschka-Dierich C., Werner F.J., Bauer I., and Fleckenstein B., J Virol44 295–310, 1982.

  14. 14.

    Schirm S., Muller I., Desrosiers R.C., and Fleckenstein B., J Virol49 938–946, 1984.

  15. 15.

    Medveczky P., Szomolanyi E., Desrosiers R.C., and Mulder C., J Virol52 938–944, 1984.

  16. 16.

    Geck P., Whitaker S., Medveczky M., and Medveczky P., J Virol64 3509–3515, 1990.

  17. 17.

    Biesinger B., Trimble J., Desrosiers R.C., and Fleckenstein B., Virology176 505–514, 1990.

  18. 18.

    Ausubel F.M., Brent R., Kingston R.E., Moore D.D., Seidman J.G., Smith J.A., and Struhl K.,Current Protocols in Molecular Biology. Greene Publishing Associates and Wiley Interscience, New York, 1990.

  19. 19.

    Zakut-Houri R., Oren M., Bienz B., Lavie V., Hazum S., and Givol D., Nature306 594–597, 1983.

  20. 20.

    Kleinschmidt J.A., Dingwall C., Maier G., and Franke W.W., EMBO J5 3547–3552, 1986.

  21. 21.

    Iino T., Takeuchi K., Nam H.S., Siomi H., Sabe H., Kobayashi N., and Hatanaka M., J Gen Virol67 1373–1379, 1986.

  22. 22.

    Szomolanyi E., Medveczky P., and Mulder C., J Virol.61 3485–3490, 1987.

  23. 23.

    Jung J.U., Trimble J.J., King N.W., Biesinger B., Fleckenstein B., and Desrosiers R.C., Proc Natl Acad Sci USA88 7051–7055, 1991.

  24. 24.

    Jung J.U. and Desrosiers R.C., J Virol65 6953–6960, 1991.

  25. 25.

    Buttle B.J. and Ehrlich H.P., J Cell Physiol116 159–166, 1983.

  26. 26.

    Liotta L.A., Vembu D., Kleinman H.K., Martin G.R., and Boone C., Nature272 622–624, 1978.

  27. 27.

    Smith B.D., Mahoney A.P., and Feldman R.S., Cancer Res43 4275–4282, 1983.

  28. 28.

    Waterhouse E.J., Quisenberry P.J., and Balian G. J Cell Physiol127 397–402, 1986.

  29. 29.

    Sage H., Biochemistry24 7430–7440, 1985.

  30. 30.

    DePetro G., Barlati S., Vartio T., and Vaheri A., Proc Natl Acad Sci USA78 4965–4969, 1981.

  31. 31.

    Humphries M.J. and Ayad S.R., Nature305 811–813, 1983.

  32. 32.

    Buck C.A. and Horwitz A.F., Ann Rev Cell Biol3 179–205, 1987.

  33. 33.

    Hemler M.E., Huang C., and Schwarz L., J Biol Chem262 3300–3309, 1987.

  34. 34.

    Hemler M.E., Jacobson J.G., and Strominger J.L., J Biol Chem260 15246–15252, 1985.

  35. 35.

    Mentzer S.J., Gromkowsky S.H., Kremsky A.M., Burakoff S.J., and Martz E. J. Immunol.135 9–11, 1985.

  36. 36.

    Ruoslahti E., Ann Rev Biochem57 375–413, 1988.

  37. 37.

    Murthy S.C.S., Trimble J.J., and Desrosiers R.C., J Virol63 3307–3314, 1989.

  38. 38.

    Lee S.I., Murthy S.C.S., Trimble J.L., Desrosiers R.C., and Steitz J.A., Cell54 599–607, 1988.

  39. 39.

    Albrecht J., Nicholas J., Biller D., Cameron K.R., Biesinger B., Newman C., Wittman S., Craxton M.A., Coleman H., Fleckenstein B., and Honess R.W., J Virol66 5047–5058, 1992.

  40. 40.

    Medveczky M.M., Geck P., Sullivan J.L., Serbousek D., Djeu J.Y., and Medveczky P.G. Virology196 402–412, 1993.

Download references

Author information

Correspondence to Dr. Peter G. Medveczky.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Medveczky, M.M., Geck, P., Vassallo, R. et al. Expression of the collagen-like putative oncoprotein ofHerpesvirus saimiri in transformed T cells. Virus Genes 7, 349–365 (1993). https://doi.org/10.1007/BF01703391

Download citation

Key words

  • herpesvirus saimiri
  • oncogene
  • collagen
  • bicistronic eukaryotic mRNA
  • T cells
  • CD8